These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 31499007)

  • 1. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid biopsies in urological cancers: what we need to know before starting using them.
    Franceschini T; Giunchi F; Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L; Fiorentino M
    Expert Rev Mol Diagn; 2020 Feb; 20(2):135-139. PubMed ID: 31509027
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
    Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
    Ellinger J; Gevensleben H; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
    Reese M; Dhayat SA
    J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
    Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
    Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular Vesicles and Their Role in Urologic Malignancies.
    Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G
    Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles in urological malignancies: an update.
    Linxweiler J; Junker K
    Nat Rev Urol; 2020 Jan; 17(1):11-27. PubMed ID: 31827264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
    Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology.
    Hu W; Liu C; Bi ZY; Zhou Q; Zhang H; Li LL; Zhang J; Zhu W; Song YY; Zhang F; Yang HM; Bi YY; He QQ; Tan GJ; Sun CC; Li DJ
    Mol Cancer; 2020 Jun; 19(1):102. PubMed ID: 32503543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy in germ cell tumors: biology and clinical management.
    Chovanec M; Kalavska K; Mego M; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
    [No Abstract]   [Full Text] [Related]  

  • 13. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
    [No Abstract]   [Full Text] [Related]  

  • 14. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review.
    Francavilla A; Turoczi S; Tarallo S; Vodicka P; Pardini B; Naccarati A
    Mutagenesis; 2020 Jul; 35(3):243-260. PubMed ID: 31784760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can biomarkers assist the prognosis of urologic malignancies?
    Falzarano SM; Feely MM
    Expert Rev Mol Diagn; 2020 Feb; 20(2):131-133. PubMed ID: 31495243
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular vesicles: Toward a clinical application in urological cancer treatment.
    Urabe F; Kosaka N; Kimura T; Egawa S; Ochiya T
    Int J Urol; 2018 Jun; 25(6):533-543. PubMed ID: 29726046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating non-coding RNAs in chronic kidney disease and its complications.
    van Zonneveld AJ; Zhao Q; Rotmans JI; Bijkerk R
    Nat Rev Nephrol; 2023 Sep; 19(9):573-586. PubMed ID: 37286733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
    Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
    Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer and the Other Non-Coding RNAs.
    Dvorská D; Braný D; Ňachajová M; Halašová E; Danková Z
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33807045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.